FOLH1 and prostate carcinoma: The discovery of PSMA was enabled by many researchers working in the 1970s and 1980s to develop a stable in vitro cell line of human prostate carcinoma, while preserving several key characteristics, including functional differentiation, malignant properties, possessing an aneuploid male karyotype, and expression of a high-affinity androgen receptor.